P. Gordon

A. Khandji, H. Mitsumoto, P. Gordon, 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

H. Gendelman, P. Gordon, S. Przedborski, 2008, PloS one.

Predicting Survival of Patients with Amyotrophic Lateral Sclerosis at Presentation: A 15-Year Experience

V. Meininger, F. Salachas, A. Elbaz, 2012, Neurodegenerative Diseases.

New therapy options for amyotrophic lateral sclerosis

V. Meininger, P. Corcia, P. Gordon, 2013, Expert opinion on pharmacotherapy.

Randomized controlled phase II trial of glatiramer acetate in ALS

H. Mitsumoto, P. Gordon, S. Przedborski, 2006, Neurology.

Lymphoproliferative disorders and motor neuron disease

E D Louis, R. Lovelace, E. Louis, 1997, Neurology.

Is there a paraneoplastic ALS?

P. Corcia, P. Gordon, J. Camdessanché, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: Discrete entities or spectrum?

M. Strong, P. Gordon, 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Metabolomics in amyotrophic lateral sclerosis: how far can it take us?

P. Vourc'h, P. Corcia, P. Gordon, 2016, European journal of neurology.

Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis

V. Meininger, P. Vourc'h, C. Andres, 2011, Journal of the Neurological Sciences.

The glutamate hypothesis in ALS: pathophysiology and drug development.

P. Corcia, P. Gordon, H. Blasco, 2014, Current medicinal chemistry.

Outcome measures for early phase clinical trials

S. Albert, H. Mitsumoto, P. Gordon, 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Vitamin D is Not a Protective Factor in ALS

C. Andres, P. Corcia, P. Gordon, 2015, CNS neuroscience & therapeutics.

Early electrodiagnostic findings in Guillain-Barré syndrome.

P. Gordon, A. Wilbourn, 2001, Archives of neurology.

Brait-Fahn-Schwarz disease: The missing link between ALS and Parkinson's disease

P. Corcia, P. Gordon, B. de Toffol, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The importance of the SMN genes in the genetics of sporadic ALS

C. Andres, P. Corcia, P. Gordon, 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Respiratory onset in an ALS family with L144F SOD1 mutation

P. Vourc'h, P. Corcia, P. Gordon, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Randomized control trials in ALS: lessons learned

H. Mitsumoto, P. Gordon, S. Przedborski, 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis

H. Mitsumoto, P. Gordon, Jiesheng Lu, 2007, Journal of the Neurological Sciences.

Biomarkers in amyotrophic lateral sclerosis: combining metabolomic and clinical parameters to define disease progression

P. Corcia, P. Gordon, L. Nadal-Desbarats, 2016, European journal of neurology.

Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis

V. Meininger, F. Salachas, P. Corcia, 2012, PloS one.

The P413L chromogranin B variation in French patients with sporadic amyotrophic lateral sclerosis

P. Vourc'h, C. Andres, P. Corcia, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Correlates of quality of life in ALS: Lessons from the minocycline study

J. Lou, Robert G. Miller, D. Moore, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Absence of the OPTN mutation in a patient with ALS and familial primary open angle glaucoma

P. Vourc'h, P. Corcia, P. Gordon, 2011, Journal of Neurological Sciences.

Pure cerebellar ataxia linked to large C9orf72 repeat expansion

V. Meininger, P. Vourc'h, C. Andres, 2016, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The murky path to drug discovery in ALS becomes clearer

P. Gordon, 2013, The Lancet Neurology.

Amyotrophic lateral sclerosis with ragged-red fibers.

S. Dimauro, C. Angelini, H. Mitsumoto, 2008, Archives of neurology.

Pathogenic Lrrk 2 substitutions and Amyotrophic lateral sclerosis

M. Farrer, Z. Wszolek, P. Gordon, 2007 .

Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis

M. Farrer, Z. Wszolek, P. Gordon, 2007, Journal of neural transmission.

Erroneous diagnosis corrected after 28 years. Not spinal muscular atrophy with ophthalmoplegia but minicore myopathy.

R. Lovelace, R. Rosenberg, P. Gordon, 1996, Archives of Neurology.

Safety of home parenteral nutrition in patients with amyotrophic lateral sclerosis: A French national survey

V. Meininger, F. Salachas, N. le Forestier, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Diagnosis in neuromuscular diseases.

P. Gordon, D. Younger, 1996, Neurologic clinics.

Woman with a 26‐year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes

D. Eidelberg, S. Fahn, S. Chin, 2004, Movement disorders : official journal of the Movement Disorder Society.

A common functional allele of the Nogo receptor gene, reticulon 4 receptor (RTN4R), is associated with sporadic amyotrophic lateral sclerosis in a French population

M. Palkovits, P. Vourc'h, C. Andres, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis

P. Vourc'h, C. Andres, P. Corcia, 2014, Molecular Neurobiology.

Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives.

R. Holman, J. Mehal, P. Gordon, 2013, JAMA neurology.

1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis

Patrick Emond, Caroline Moreau, David Devos, 2010, PloS one.

Encephalitis-associated hospitalizations among American Indians and Alaska Natives.

R. Holman, J. Mehal, J. Blanton, 2014, The American journal of tropical medicine and hygiene.

Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

P. Gordon, 2013, Aging and disease.

Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

Lucette Lacomblez, Vincent Meininger, Dominique Simon, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS

J. Lou, A. Pestronk, H. Andrews, 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

H. Mitsumoto, Robert G. Miller, R. Barohn, 2007, The Lancet Neurology.

Translational Research in ALS

P. Gordon, C. Cheroni, C. Bendotti, 2008 .

Lymphoproliferative disorders and motor neuron disease

R. Lovelace, W. Trojaborg, P. Gordon, 1998, Neurology.

The natural history of primary lateral sclerosis

H. Mitsumoto, P. Gordon, L. Rowland, 2006, Neurology.

Correction: 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis

Patrick Emond, Caroline Moreau, David Devos, 2010, PLoS ONE.

Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry.

Patrick Emond, Caroline Moreau, David Devos, 2013, Journal of proteome research.

Glatiramer acetate immunization induces specific antibody and cytokine responses in ALS patients

H. Gendelman, H. Mitsumoto, P. Gordon, 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

The range and clinical impact of cognitive impairment in French patients with ALS: A cross-sectional study of neuropsychological test performance

V. Meininger, F. Salachas, P. Gordon, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

A prospective cohort study of neuropsychological test performance in ALS

K. Marder, Y. Stern, R. Goetz, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

A screening assessment of cognitive impairment in patients with ALS

K. Marder, H. Mitsumoto, Yuanjia Wang, 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Oxidative stress biomarkers in sporadic ALS

M. Bogdanov, H. Mitsumoto, R. Santella, 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Amyotrophic Lateral Sclerosis and Dementia

P. Corcia, P. Gordon, Kate Dalton, 2015 .

Prevalence of fatigue and depression in ALS patients and change over time

R. Goetz, J. Rabkin, M. McElhiney, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

APOE ε4 allele is associated with an increased risk of bulbar‐onset amyotrophic lateral sclerosis in men

P. Vourc'h, C. Andres, P. Corcia, 2011, European journal of neurology.

Chapter 20 Symptomatic therapy and palliative aspects of clinical care.

H. Mitsumoto, P. Gordon, 2007, Handbook of clinical neurology.

Progression in ALS is not linear but is curvilinear

Lucette Lacomblez, Vincent Meininger, V. Meininger, 2010, Journal of Neurology.

Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial

John L.P. Thompson, H. Mitsumoto, P. Gordon, 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

The ALSFRSr predicts survival time in an ALS clinic population

P. Kaufmann, John L.P. Thompson, G. Levy, 2005, Neurology.

Extensor digitorum brevis test and resistance to botulinum toxin type A

P. Gordon, C. Gooch, P. Greene, 2002, Muscle & nerve.

THEME 10 MULTIDISCIPLINARY CARE AND QUALITY OF LIFE

E. Lindeman, P. Gordon, J. Schelhaas, 2008 .

Prevalence of Parkinson disease among the Navajo: a preliminary examination.

Hongwei Zhao, P. Gordon, A. Rowland, 2013, Journal of Parkinson's disease.

DOPA-RESPONSIVE DYSTONIC CAMPTOCORMIA

Ying Kuen Cheung, Y. Cheung, P. Gordon, 2006, Neurology.

Quantitative objective markers for upper and lower motor neuron dysfunction in ALS

S L Pullman, J. Hirsch, J. Hirsch, 2007, Neurology.

Motor unit number estimation (MUNE) in diseases of the motor neuron: utility and comparative analysis in a multimodal biomarker study.

A. Uluğ, S. Pullman, H. Mitsumoto, 2009, Supplements to Clinical neurophysiology.

Dissociating apathy and depression in Parkinson disease

D. Goodin, Y. Cheung, T. Hanafusa, 2006, Neurology.

ALSFRS‐R

Robert G. Miller, P. Gordon, D. Moore, 2004, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

Untargeted 1H-NMR metabolomics in CSF

D. Devos, C. Moreau, C. Andres, 2014, Neurology.

An observational study of cognitive impairment in amyotrophic lateral sclerosis.

Yaakov Stern, Karen Marder, Hiroshi Mitsumoto, 2006, Archives of neurology.

Defining survival as an outcome measure in amyotrophic lateral sclerosis.

V. Meininger, M. Cudkowicz, P. Leigh, 2009, Archives of neurology.

Lou Gehrig, Rawhide, and 1938

P. Gordon, Melissa Lewis, 2007, Neurology.

History of ALS

P. Gordon, 2005 .

Clinical features that distinguish PLS, upper motor neuron–dominant ALS, and typical ALS

H. Mitsumoto, P. Gordon, L. Rowland, 2009, Neurology.

Amyotrophic lateral sclerosis: A hormonal condition?

C. Andres, P. Corcia, P. Gordon, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Improving survival in a large French ALS center cohort

V. Meininger, F. Salachas, C. Morélot-Panzini, 2012, Journal of Neurology.

A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis

P. Gordon, 2009, Muscle & nerve.

Modafinil treatment of fatigue in patients with ALS: A placebo‐controlled study

J. Rabkin, M. McElhiney, H. Mitsumoto, 2009, Muscle & nerve.

The Timed Up and Go test: Predicting falls in ALS

Hiroshi Mitsumoto, Jacqueline Montes, H. Mitsumoto, 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Advances in clinical trials for amyotrophic lateral sclerosis

P. Gordon, 2005, Current neurology and neuroscience reports.

| Amyotrophic Lateral Sclerosis | Taylor & Francis Group

H. Mitsumoto, P. Gordon, S. Przedborski, 2005 .

Central pontine myelinolysis: clinical syndrome with normal serum sodium.

J. Mohr, T. Tatemichi, P. Gordon, 1995, European journal of medical research.

Reaction time and movement time after embryonic cell implantation in Parkinson disease.

S. Fahn, S. Pullman, P. Gordon, 2004, Archives of neurology.

Selecting promising ALS therapies in clinical trials

Y. Cheung, P. Gordon, B. Levin, 2006, Neurology.